Viking Therapeutics, Inc. (VKTX)
Viking Therapeutics, Inc. (VKTX)
$8.02 USD
Updated Jun 25 8:00pm
Add VKTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 207 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
VKTX News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Tesla (TSLA) shares are down after Electrek says it may miss its 2Q delivery target
Tyson Foods (TSN) shares dive on report that it’s being investigated for price fixing
Shares of marijuana firm Hexo (HEXO) tank following downgrade from Oppenheimer
Why UBS says recent strength in Hostess (TWNK) shares have a lot more upside
Why investors shouldn’t be in a hurry to buy Cronos Group (CRON) shares
View All Top StoriesViking Therapeutics, Inc. (VKTX) Company Bio
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead clinical program, VK5211, is an orally available, non-steroidal selective androgen receptor modulator in Phase II development for the treatment of patients recovering from non-elective hip fracture surgery; in Phase I clinical trials for improving lean body mass; and in pre-clinical trial for improving bone mineral density, bone mineral content, bone strength, and other measures. The company is also developing VK2809, an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta, which is in a Phase II clinical trial for the treatment of patients with hypercholesterolemia and fatty liver disease; and in a Phase I clinical trial to treat patients who suffer from glycogen storage disease type Ia. In addition, it is developing VK0214 for X-linked adrenoleukodystrophy, which is in pre-clinical stage. Viking Therapeutics, Inc. was founded in 2012 and is based in San Diego, California.
VKTX Stock Chart More Charts
VKTX Price/Volume Stats
| Current price | $8.02 |
| Prev. close | $7.95 |
| Day low | $7.95 |
| Day high | $8.18 |
| 50-day MA | $8.24 |
| 200-day MA | $10.11 |
| 52-week high | $24.00 |
| 52-week low | $6.97 |
| Volume | 1,463,600 |
| Avg. volume | 2,754,150 |
| Dividend yield | N/A |
| Market Cap | 577.82M |
VKTX Returns
| 1-mo | -6.09% |
| 3-mo | -5.76% |
| 6-mo | 5.94% |
| 1-year | -22.96% |
| 3-year | 546.77% |
| 5-year | N/A |
| YTD | 4.84% |
| 2018 | 88.42% |
| 2017 | 241.18% |
| 2016 | -65.10% |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...